Researchers Identified New Tuberculosis Agent
A natural soil compound has shown success against drug-resistant tuberculosis strains in new research.
Updated on Sept. 23, 2026 in Life Sciences
Live Poll
Do you believe natural compound research is the most promising path to curing drug-resistant diseases?
Scientists have identified corramycin, a compound found in soil bacteria, as a potential new treatment for drug-resistant tuberculosis. The substance effectively targets the bacteria by damaging its essential DNA gyrase enzyme.
Why it matters
Current tuberculosis antibiotics are losing effectiveness against drug-resistant strains, posing a global health risk to the approximately 10 million people who contract the disease annually. This discovery offers a potential pathway to treat infections that no longer respond to conventional medicine.
Researchers utilized cryo-electron microscopy to observe corramycin binding to DNA gyrase. This process prevents the enzyme from rejoining DNA strands after it cuts them, causing fatal damage to the bacterial genetic material.
The players
HIPS
This is a research institute located in Saarbrücken focused on pharmaceutical sciences.
Institut Pasteur
Located in Paris, this international research center is dedicated to the study of biology and diseases.
Université Paris Cité
This is a prominent French public university involved in collaborative life sciences research.
The details
Corramycin remains potent against tuberculosis strains that have developed resistance to fluoroquinolones. While the compound was previously studied for use against Gram-negative bacteria, development was stalled due to high production costs.
Timeline
Research findings were published on September 23, 2026.
HIPS was founded in 2009 by HZI and Saarland University.
The Big Picture
This discovery marks a shift in how scientists approach drug-resistant infections by re-evaluating natural compounds with unique binding mechanisms. The study follows the long-term mission of the Helmholtz Institute for Pharmaceutical Research Saarland to discover novel antimicrobial agents.
While not yet available for clinical use, this research suggests a future where drug-resistant tuberculosis can be treated more effectively. Successfully optimizing corramycin could eventually lead to new, life-saving medications for patients currently lacking treatment options.
The takeaway
Natural compounds found in soil continue to be a vital frontier for developing new antibiotics against resistant pathogens. Researchers must now focus on overcoming the historical barriers of production costs and pharmacokinetics to bring this agent closer to clinical reality.
Further reading
For more on evolving medical breakthroughs, explore the latest in Life Sciences.
More information
Read the full scientific study publication in Advanced Science for detailed methodology.
Live Poll
Do you believe natural compound research is the most promising path to curing drug-resistant diseases?
